BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25439451)

  • 21. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation.
    De Backer O; Arnous S; Sandholt B; Brooks M; Biasco L; Franzen O; Lönn L; Bech B; Søndergaard L
    Am J Cardiol; 2015 Apr; 115(8):1123-9. PubMed ID: 25728645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 30-Day Outcomes of Transfemoral Versus Transapical Approach for Transcatheter Aortic Valve Replacement: A Single-Center US Experience.
    Murarka S; Lazkani M; Neihaus M; Boggess M; Morris M; Gellert G; Fang HK; Pershad A
    Ann Thorac Surg; 2015 May; 99(5):1539-44. PubMed ID: 25754964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors and incidence of access site complications in transcatheter aortic valve implantation with the use of new delivery systems.
    Sari C; Ayhan H; Aslan AN; Durmaz T; Keleş T; Baştuğ S; Bayram NA; Bilen E; Kasapkara HA; Bozkurt E
    Perfusion; 2015 Nov; 30(8):666-74. PubMed ID: 25795681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of Stent Graft Implantation for Treatment of Access Site Bleeding After Transfemoral Transcatheter Aortic Valve Replacement.
    Segal A; Flugelman MY; Khader N; Rubinshtein R; Lavi I; Karmeli R; Jubran A; Shiran A; Jaffe R
    Am J Cardiol; 2017 Aug; 120(3):456-460. PubMed ID: 28583682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of TransFemoral Transcatheter Aortic Valve Replacement Performed With a Minimally Invasive Simplified Technique: "FAST" Versus a Standard Approach.
    Lefèvre G; Jégou A; Dambrin G; Picard F; Anconina J; Pouzet B; Guesnier L; Cheikh Khelifa R; Hilpert L; Doan HL; Favereau X
    J Invasive Cardiol; 2019 Oct; 31(10):300-306. PubMed ID: 31567114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early discharge after transfemoral transcatheter aortic valve implantation.
    Barbanti M; Capranzano P; Ohno Y; Attizzani GF; Gulino S; Immè S; Cannata S; Aruta P; Bottari V; Patanè M; Tamburino C; Di Stefano D; Deste W; Giannazzo D; Gargiulo G; Caruso G; Sgroi C; Todaro D; di Simone E; Capodanno D; Tamburino C
    Heart; 2015 Sep; 101(18):1485-90. PubMed ID: 26076940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brachiocephalic artery access in transcatheter aortic valve implantation: a valuable alternative: 3-year institutional experience.
    Philipsen TE; Collas VM; Rodrigus IE; Salgado RA; Paelinck BP; Vrints CM; Bosmans JM
    Interact Cardiovasc Thorac Surg; 2015 Dec; 21(6):734-40. PubMed ID: 26395943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches.
    Kadakia MB; Herrmann HC; Desai ND; Fox Z; Ogbara J; Anwaruddin S; Jagasia D; Bavaria JE; Szeto WY; Vallabhajosyula P; Li R; Menon R; Kobrin DM; Giri J
    Circ Cardiovasc Interv; 2014 Aug; 7(4):570-6. PubMed ID: 25027520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry.
    Sinning JM; Horack M; Grube E; Gerckens U; Erbel R; Eggebrecht H; Zahn R; Linke A; Sievert H; Figulla HR; Kuck KH; Hauptmann KE; Hoffmann E; Hambrecht R; Richardt G; Sack S; Senges J; Nickenig G; Werner N
    Am Heart J; 2012 Jul; 164(1):102-10.e1. PubMed ID: 22795289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions.
    Steinvil A; Leshem-Rubinow E; Halkin A; Abramowitz Y; Ben-Assa E; Shacham Y; Bar-Dayan A; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2015 Jan; 115(1):100-6. PubMed ID: 25456874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
    Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
    Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
    Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
    Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation.
    Van Mieghem NM; Tchetche D; Chieffo A; Dumonteil N; Messika-Zeitoun D; van der Boon RM; Vahdat O; Buchanan GL; Marcheix B; Himbert D; Serruys PW; Fajadet J; Colombo A; Carrié D; Vahanian A; de Jaegere PP
    Am J Cardiol; 2012 Nov; 110(9):1361-7. PubMed ID: 22819428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transradial Secondary Approach During Transfemoral TAVI: Usefulness of Placing a Wire Before Femoral Puncture for Management and Treatment of Vascular Complications.
    Unzué L; García E; Teijeiro R; Del Río MR; Díaz-Antón B; Rodrigo FJR; Parra FJ
    Cardiovasc Revasc Med; 2021 Feb; 23():94-99. PubMed ID: 32788092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
    Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and predictors of vascular access site complications following transfemoral transcatheter aortic valve implantation.
    Fonseca P; Almeida J; Bettencourt N; Ferreira N; Carvalho M; Ferreira W; Caeiro D; Gonçalves H; Ribeiro J; Rodrigues A; Braga P; Gama V
    Rev Port Cardiol; 2017 Oct; 36(10):747-753. PubMed ID: 27432771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Das TM; Shin J; Czarny MJ; Nanavati J; Resar JR; Hasan RK
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1225-1233. PubMed ID: 34792259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
    J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
    Urbach J; Hou CR; Lesser JR; Stanberry LI; Garberich RF; Caye D; Sorajja P; Gössl M
    Am J Cardiol; 2019 Jul; 124(1):98-104. PubMed ID: 31029410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.